Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)

Department of Health and Human Services National Institutes of Health
Posted on

Application Deadline

Type

Research/project funding

Reference Number

PAR-23-063

The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions through awards for three sequential five-year phases. The purpose of the COBRE Phase 2 award is to strengthen successful COBRE Phase 1 centers established in Phase 1 through further improvements to research infrastructure and the continued development of a critical mass of investigators with shared scientific interests who are able to compete effectively for independent research funding and further improvements to research infrastructure at the institution.
Categories: Health.

More Information

Posted on

Application Deadline

Type

Research/project funding

Reference Number

PAR-23-063

United States